Search results

Selected filters:

Europe

Article type

Topic

Sector

Jurisdictions

12,689 results found for your search

Sort options
16 July 2019

Gilead’s unique $5.1 billion licensing deal shows the range of IP monetisation options open to biotech sector

New boss explains that the Big Pharma company will seek out “diverse and creative” asset partnerships – rather than large acquisitions – to boost its pipeline

10 July 2019

Hydrophobic coatings and the drive to replace plastic packaging

Analysis of patent publications indicates that innovators are filing an increasing number of patent applications related to superhydrophobic technologies. However, there are some considerations that should be taken into account when drafting such applications.

10 July 2019

All the big life sciences IP developments in June

Our round-up of the major patent issues affecting pharma and biotech that emerged on the legal, market and policy fronts last month

05 July 2019

Get ready for the first CRISPR patent pool

In an exclusive interview, MPEG LA’s Kristin Neuman says that a pool is on its way despite the UCal v Broad stand-off and talks about the future of licensing in biotech’s ‘golden age’

03 July 2019

Law firm’s patent attorney deal shows changing face of IP practice in the UK

Lewis Silkin’s acquisition of Ablett & Stebbing is a first and demonstrates just how far things have moved in a once conservative market

03 July 2019

Employer versus employee: and the winner is…

In a recent decision, the Court of Milan has offered a broad interpretation of employers’ rights to patents filed by employees where the patents are in the employer’s general field. It opined that the employer should be favoured in the case at hand as the inventive act was carried out under an employment contract, although the employee could still be entitled to a reward.

02 July 2019

Japanese aircon giant latest to pledge patent non-aggression

Ten years ago, the company bet big on sharing technology with Chinese upstarts. Now Daikin is opening up a portfolio of refrigerant patents

02 July 2019

AbbVie’s Allergan play designed to mitigate Humira patent cliff

The $63 billion purchase is designed to mitigate the effects of losing the exclusive rights to the world’s best selling drug

27 June 2019

Huawei has reaped $1.4 billion in licence fees since 2015, white paper says

The Chinese company also revealed its royalty outflow – $6 billion since it took its first licence in 2001, 80% of which has gone to US companies

27 June 2019

Everything you wanted to know about AI patents, but were afraid to ask - part 2

After a WIPO report in April, new analysis from the UK IP Office sheds further light on this rapidly growing area and confirms that, despite a Chinese filing surge, the US continues to dominate

26 June 2019

Despite UK High Court setback for Pfizer, Arrow declarations remain a valuable litigation tool

The latest judgment is one of only a few to provide an indication of when the courts will grant the pre-emptive litigation defence remedy, which was issued for the first time in 2017

26 June 2019

SPC manufacturing waiver is poised to go

The EU Regulation on Supplementary Protection Certificates (SPC) for Medicinal Products is due to enter into force on 1 July 2019. The legislation introduces a long-awaited SPC manufacturing waiver, which aims to remedy the unintended consequences of the current SPC model and react to the changes that have occurred in the pharmaceutical industry over the last three decades.

26 June 2019

IP court decisions cast doubt on preliminary injunctions

It has become common for plaintiffs in an invalidation or determination of non-infringement action to demand a precautionary injunction against a defendant patentee to prevent it from enforcing its rights. However, recent case law suggests that the issue is far from straightforward.

20 June 2019

US tells WTO to hit pause on China IP complaint

Suspension of the probe may not herald a broader deal, but it does underscore the significant legislative concessions China has made on tech transfer and other IP issues

20 June 2019

Another year, another benchmarking survey and the EPO is top once more

Boost for António Campinos as he ends the first year of his presidency; and good news, too, for USPTO head Andrei Iancu